Author Question: If the United States negotiates a voluntary export restraint with international sugar producing ... (Read 92 times)

brutforce

  • Hero Member
  • *****
  • Posts: 540
If the United States negotiates a voluntary export restraint with international sugar producing nations, then
 
  A) U.S. sugar buyers pay a lower price for sugar.
  B) U.S. sugar producers produce a smaller quantity.
  C) imports of sugar increase.
  D) the U.S. government collects less revenue than if it imposed a tariff on sugar.
  E) the foreign governments collect more revenue than if a tariff is imposed on sugar.

Question 2

Other things remaining the same, which of the following is likely to happen if all homemakers in an economy start working as paid labor?
 
  A) There will be a fall in both the wage rate and the employment level.
  B) There will be an increase in both the wage rate and the employment level.
  C) There will be an increase in the wage rate in the country and a fall in the employment level.
  D) There will be a fall in the wage rate in the country and an increase in the employment level.


upturnedfurball

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

D

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library